 |
|
|
| |
FOSTEMSAVIR DRUG-DRUG INTERACTION PROFILE, AN ATTACHMENT INHIBITOR AND ORAL PRODRUG OF TEMSAVIR, FOR PATIENTS WITH MULTIDRUG-RESISTANT HIV-1 INFECTION
|
| |
| |
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs Virtual Meeting, September 28-30, 2020
Reported by Jules Levin
Katy Moore,1 Elana Post,2 A. Savannah Mageau,2 Mindy Magee,3 Pete Gorycki,4 Peter Ackerman,5 Cyril Llamoso5
1Clinical Pharmacology, ViiV Healthcare, Research Triangle Park, NC, USA; 2PharmD Candidate, UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA; 3Clinical Pharmacology Modeling Simulation, GlaxoSmithKline, Upper Providence, PA, USA; 4Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Upper Providence, PA, USA; 5Clinical Development, ViiV Healthcare, Branford, CT, USA
|
| |
|
|
|
|
|
